Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Tang, Ling ^a   Zhao, Ying ^a   Wang, Daoxin ^a   Deng, Wang ^a   Li, Changyi ^a   Li, Qi ^b   Huang, Shicong ^a   Shu, Chang ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Xinqiao Hospital   (China)

^c Respiratory Department Tong Liang County People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOCAN; PROCALCITONIN; UNCLASSIFIED DRUG; ESM1 PROTEIN, HUMAN; PROTEOGLYCAN; TUMOR PROTEIN;

ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEUTROPHIL; OBSTRUCTIVE AIRWAY DISEASE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; SHOCK; STATISTICAL SIGNIFICANCE; VIRUS PNEUMONIA; ADOLESCENT; BLOOD; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; APACHE; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; NEOPLASM PROTEINS; PROTEOGLYCANS; RESPIRATORY DISTRESS SYNDROME, ADULT; YOUNG ADULT;

EID: 84924990492     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/625180     Document Type: Article

References (24)

1. J. Phua, J. R. Badia, N. K. J. Adhikari et al. , "Has mortality fromacute respiratory distress syndrome decreased over time?" American Journal of Respiratory and Critical CareMedicine, vol. 179, no. 3, pp. 220-227, 2009.
2. G. D. Rubenfeld and M. S. Herridge, "Epidemiology and outcomes of acute lung injury, " Chest, vol. 131, no. 2, pp. 554-562, 2007.
3. M. S. Herridge, C. M. Tansey, A. Matte et al. , "Functional disability 5 years after acute respiratory distress syndrome, " The NewEngland Journal ofMedicine, vol. 364, no. 14, pp. 1293-1304, 2011.
4. F. Stuber, H. Wrigge, S. Schroeder et al. , "Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury, " Intensive Care Medicine, vol. 28, no. 7, pp. 834-841, 2002.
5. L. B. Ware, T. Koyama, D. D. Billheimer et al. , "Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury, " Chest, vol. 137, no. 2, pp. 288-296, 2010.
6. P. Prabhakaran, L. B. Ware, K. E. White, M. T. Cross, M. A. Matthay, and M. A. Olman, "Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury, " The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 285, no. 1, pp. L20-L28, 2003.
7. L. B. Ware, X. Fang, and M. A. Matthay, "Protein C and thrombomodulin in human acute lung injury, " The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 285, no. 3, pp. L514-L521, 2003.
8. H. Sato, M. E. J. Callister, S. Mumby et al. , "KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome, " European Respiratory Journal, vol. 23, no. 1, pp. 142-145, 2004.
9. R. M. Determann, A. A. N. M. Royakkers, J. J. Haitsma et al. , "Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients, " BMC Pulmonary Medicine, vol. 10, article 6, 2010.
10. T. Nakamura, E. Sato, N. Fujiwara, Y. Kawagoe, S. Maeda, and S. Yamagishi, "Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome, " Clinical Biochemistry, vol. 44, no. 8-9, pp. 601-604, 2011.
11. A. Agrawal, M. A. Matthay, K. N. Kangelaris et al. , "Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients, " American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 7, pp. 736-742, 2013.
12. T. Uchida, M. Shirasawa, L. B. Ware et al. , "Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury, " The American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 9, pp. 1008-1015, 2006.
13. C. S. Calfee, M. D. Eisner, P. E. Parsons et al. , "Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury, " Intensive Care Medicine, vol. 35, no. 2, pp. 248-257, 2009.
14. P. Lassalle, S. Molet, A. Janin et al. , "ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines, " Journal of Biological Chemistry, vol. 271, no. 34, pp. 20458-20464, 1996.
15. D. Bechard, V. Meignin, A. Scherpereel et al. , "Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies, " Journal of Vascular Research, vol. 37, no. 5, pp. 417-425, 2000.
16. D. Bechard, A. Scherpereel, H. Hammad et al. , "Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1, " Journal of Immunology, vol. 167, no. 6, pp. 3099-3106, 2001.
17. A. Scherpereel, F. Depontieu, B. Grigoriu et al. , "Endocan, a new endothelial marker in human sepsis, " Critical Care Medicine, vol. 34, no. 2, pp. 532-537, 2006.
18. D. M. Mihajlovic, D. F. Lendak, S. V. Brkic et al. , "Endocan is useful biomarker of survival and severity in sepsis, " Microvascular Research, vol. 93, pp. 92-97, 2014.
19. V. M. Ranieri, G. D. Rubenfeld, B. T. , " Thompson et al. Acute respiratory distress syndrome: the Berlin definition, " The Journal of the American Medical Association, vol. 307, 23, 2526-2533, 2012.
20. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, "APACHE II: a severity of disease classification system, " Critical Care Medicine, vol. 13, no. 10, pp. 818-829, 1985.
21. M. L. Terpstra, J. Aman, G. P. van Nieuw Amerongen, and A. B. Groeneveld, "Plasma biomarkers for acute respiratory distress syndrome: a systematic review andmeta-analysis, " Critical Care Medicine, vol. 42, no. 3, pp. 691-700, 2014.
22. H. Lee, "Procalcitonin as a biomarker of infectious diseases, " Korean Journal of Internal Medicine, vol. 28, no. 3, pp. 285-291, 2013.
23. M. E. Mikkelsen, C. V. Shah, A. Scherpereel et al. , "Lower serum endocan levels are associated with the development of acute lung injury after major trauma, " Journal of Critical Care, vol. 27, no. 5, pp. 522. e11-522. e17, 2012.
24. C. S. Calfee, M. D. Eisner, L. B. Ware et al. , "Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders, " Critical Care Medicine, vol. 35, no. 10, pp. 2243-2250, 2007.